Your browser doesn't support javascript.
loading
[A phase II, single-arm, open-label, multicenter clinical study to evaluate the efficacy and safety of sofosbuvir combined with ribavirin in patients with genotype 2 chronic hepatitis C virus infection].
Gao, Y H; Li, G M; Jin, Q L; Zhao, Y R; Jia, Z S; Mao, X R; Yang, Y F; Shang, J; Wang, G C; Xie, W; Wu, S M; Zhang, M X; Hou, J L; Li, D L; Nan, Y M; Guan, Y J; Zhu, C X; Yuan, Y Z; Wei, L.
  • Gao YH; Department of Hepatology, Peking University People's Hospital, Beijing 100044, China (now in Peking University International Hospital).
  • Li GM; Department of Hepatology, Zhengzhou Sixth People's Hospital, Zhengzhou 450061, China.
  • Jin QL; Department of Hepatobiliary and Pancreatic, Jilin University First Hospital, Changchun 130021, China.
  • Zhao YR; Department of Infectious Disease, Xi'an Jiaotong University School of Medicine First Affiliated Hospital, Xi'an 710065, China.
  • Jia ZS; Center of Infectious Diseases and Liver Diseases, Fourth Military Medical University Tangdu Hospital, Xi'an 710038, China.
  • Mao XR; Department of Infectious Disease, Lanzhou University First Hospital, Lanzhou 730000, China.
  • Yang YF; Department of Hepatology, Nanjing Second Hospital, Nanjing 210028, China.
  • Shang J; Department of Infectious Disease, Henan Provincial People's Hospital, Zhengzhou 450003, China.
  • Wang GC; Department of Hepatology, Dalian Sixth People's Hospital, Dalian 116001, China.
  • Xie W; Center of Liver Disease Study, Beijing Ditan Hospital, Beijing 100015, China.
  • Wu SM; Department of Hepatology, Shanghai Public Health Clinical Center, Shanghai 201508, China.
  • Zhang MX; Department of Traditional and Western Medical Hepatology, Shenyang Sixth People's Hospital, Shenyang 110006, China.
  • Hou JL; Department of Infectious Disease, Southern Medical University Southern Hospital, Guangzhou 510515, China.
  • Li DL; Department of Hepatobiliary, Nanjing Military Region Fuzhou General Hospital, Fuzhou 350025, China.
  • Nan YM; Department of Traditional and Western Medical hepatology, Hebei Medical University Third Hospital, Shijiazhuang 050000, China.
  • Guan YJ; Department of Hepatology, Guangzhou Eighth People's Hospital, Guangzhou 510060, China.
  • Zhu CX; Nanjing Chia Tai Tianqing Co., Ltd, Nanjing 210000, China.
  • Yuan YZ; Nanjing Chia Tai Tianqing Co., Ltd, Nanjing 210000, China.
  • Wei L; Department of Hepatology, Peking University People's Hospital, Beijing 100044, China (now in Beijing Tsinghua Changgung Hospital).
Zhonghua Gan Zang Bing Za Zhi ; 27(5): 352-357, 2019 May 20.
Article en Zh | MEDLINE | ID: mdl-31177659
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Hepacivirus / Hepatitis C Crónica / Sofosbuvir Tipo de estudio: Clinical_trials Límite: Humans País como asunto: Asia Idioma: Zh Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Ejes tematicos: Pesquisa_clinica Banco de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Hepacivirus / Hepatitis C Crónica / Sofosbuvir Tipo de estudio: Clinical_trials Límite: Humans País como asunto: Asia Idioma: Zh Año: 2019 Tipo del documento: Article